Question 1

What's the Syncom Formulations (India) Ltd share price today?

Accepted Answer

Syncom Formulations (India) Ltd share price was Rs 13.07 at 04:01 PM IST on 19th Feb 2026. Syncom Formulations (India) Ltd share price was down by 3.83% from the previous closing price of Rs 13.59. Syncom Formulations (India) Ltd share price trend:

Last 1 Month: Syncom Formulations (India) Ltd share price moved up by 3.55% on BSE
Last 3 Months: Syncom Formulations (India) Ltd share price moved down by 18.57% on BSE
Last 12 Months: Syncom Formulations (India) Ltd share price moved down by 22.93% on BSE
Last 3 Years: Syncom Formulations (India) Ltd price moved up by 84.65% on BSE

Question 2

How can I quickly analyse the performance of the Syncom Formulations (India) Ltd stock?

Accepted Answer

The performance of the Syncom Formulations (India) Ltd stock can be quickly analysed on the following metrics:

The stock's PE is 17.96
Price to book value ratio is 3.25
Dividend yield of 0.00
The EPS (trailing 12 months) of the Syncom Formulations (India) Ltd stock is Rs 0.73

Question 3

What is the market cap of Syncom Formulations (India) Ltd?

Accepted Answer

Syncom Formulations (India) Ltd has a market capitalisation of Rs 1,229 crore.

Question 4

What is Syncom Formulations (India) Ltd's 52-week high/low share price?

Accepted Answer

The Syncom Formulations (India) Ltd’s 52-week high share price is Rs 23.46 and 52-week low share price is Rs 11.52.

Question 5

Is the Syncom Formulations (India) Ltd profitable?

Accepted Answer

On a consolidated basis, Syncom Formulations (India) Ltd reported a profit of Rs 18.91 crore on a total income of Rs 120.64 crore for the quarter ended 2025. For the year ended Dec 2025, Syncom Formulations (India) Ltd had posted a profit of Rs 18.91 crore on a total income of Rs 120.64 crore.

Question 6

Which are Syncom Formulations (India) Ltd’s peers in the Health care sector?

Accepted Answer

Syncom Formulations (India) Ltd’s top 5 peers in the Health care sector are  NGL Fine Chem, Hester Bios, Lincoln Pharma., Syncom Formul., Jagsonpal Pharma, Bajaj Healthcare, Ind-Swift Labs..

Question 7

Who owns how much in Syncom Formulations (India) Ltd?

Accepted Answer

Key changes to the Syncom Formulations (India) Ltd shareholding are as follows:

Promoter holding in Syncom Formulations (India) Ltd has gone up to 50.57 per cent as of Dec 2025 from 50.57 per cent as of Mar 2025.
Indian Public holding in Syncom Formulations (India) Ltd has gone down to 45.04 per cent as of Dec 2025 from 45.20 per cent as of Mar 2025.
Non Institutional Investors holding in Syncom Formulations (India) Ltd has gone up to 4.13 per cent as of Dec 2025 from 4.12 per cent as of Mar 2025.
Foreign Institutional Investors holding in Syncom Formulations (India) Ltd has gone up to 0.26 per cent as of Dec 2025 from 0.11 per cent as of Mar 2025.
Financial Institutions holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Dec 2025 from 0.00 per cent as of Mar 2025.
Insurance Companies holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Dec 2025 from 0.00 per cent as of Mar 2025.
Mutual Funds Uti holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Dec 2025 from 0.00 per cent as of Mar 2025.
Other Institutional Investors holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Dec 2025 from 0.00 per cent as of Mar 2025.
Custodians holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Dec 2025 from 0.00 per cent as of Mar 2025.

Market Cap (₹ Cr)	1,229
Traded Value (₹ Cr)	0.22
Volume (Shares)	1,69,460
Face Value (₹)	1

52-Week High (₹)	23.46
52-Week High Date	28-May-2025
52-Week Low (₹)	11.52
52-Week Low Date	22-Jan-2026

All Time High (₹)	27.94
All Time High Date	10-Sep-2024
All Time Low (₹)	0.14
All Time Low Date	15-Jan-1998

Syncom Formulations (India) Share Price

Syncom Formulations (India) Ltd